Business Context and Reporting Period
This Form 8-K is a current report filed by Ruthigen, Inc. (not Pulmatrix, Inc.) on November 28, 2014. The filing addresses Item 5.02 regarding the appointment of certain officers and compensatory arrangements. Specifically, the Company's compensation committee approved an amended and restated employment agreement for its Chief Executive Officer, Hojabr Alimi, superseding a prior agreement established when the Company was a subsidiary of Oculus Innovative Sciences, Inc.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The only financial metric disclosed relates to executive compensation:
- CEO Base Salary: $375,000 annually (subject to board increase).
- Severance Package (Termination without cause/Good reason):
- Lump sum payment equal to 24 times the average monthly base salary over the preceding 12 months.
- Up to one year of COBRA health care premium reimbursement.
- Automatic vesting of all unvested options and equity awards.
- Change of Control: Full immediate vesting of all outstanding unvested equity awards.
- Tax Gross-Up: Reimbursement for excise taxes under Sections 280G and 4999 of the Internal Revenue Code.
Material Changes Versus Prior Period
The primary material change is the execution of a new employment agreement that removes all references to the former parent company, Oculus Innovative Sciences, Inc., and legacy subsidiary language. The filing explicitly states that these changes do not affect or impact the equity awards granted to Mr. Alimi in May 2014.
Guidance, Outlook, Risks, and Contingencies
Management Commentary and Contingencies:
- Termination Conditions: Receipt of severance benefits is contingent upon Mr. Alimi executing a general release of claims, resigning from all directorships, returning Company property, and complying with non-competition, invention assignment, and confidentiality provisions.
- Non-Solicitation: The Company is not obligated to pay benefits if Mr. Alimi violates non-solicitation provisions, which prohibit interfering with business relations or soliciting employees for two years following termination.
- Resignation Rights: Mr. Alimi may terminate his employment for any reason with at least 60 days' prior written notice.
Outlook: The filing does not provide financial guidance or operational outlook.
Important Facts for Investor Verification
- Verify the total potential cash liability for CEO severance (24 months of salary) in the event of a termination without cause.
- Confirm the status and value of unvested equity awards held by the CEO, which accelerate upon termination or change of control.
- Note that the filing is for Ruthigen, Inc., not Pulmatrix, Inc., as indicated in the request metadata.
- Review the full text of the employment agreement (Exhibit 10.1) for specific definitions of "good reason" and "termination without cause."